Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.58% | 149.06 | 0.7% | $734.24m | |
| BMY | Bristol-Myers Squibb Co. | -0.08% | 66.73 | 1.0% | $726.64m | |
| PFE | Pfizer Inc. | -0.25% | 40.51 | 0.9% | $611.72m | |
| MRK | Merck & Co., Inc. | -0.22% | 90.98 | 0.7% | $577.92m | |
| ABBV | AbbVie, Inc. | -1.40% | 88.01 | 2.3% | $545.73m | |
| LLY | Eli Lilly & Co. | -1.29% | 139.61 | 1.1% | $400.65m | |
| APLS | Apellis Pharmaceuticals, Inc. | 0.30% | 40.50 | 0.0% | $107.43m | |
| NVS | Novartis AG | 0.88% | 95.94 | 0.2% | $101.60m | |
| AZN | AstraZeneca Plc | 1.62% | 51.33 | 1.2% | $98.49m | |
| GSK | GlaxoSmithKline Plc | 1.55% | 47.89 | 0.2% | $84.36m | |
| KRTX | Karuna Therapeutics, Inc. | 9.17% | 104.52 | 0.0% | $68.78m | |
| SNY | Sanofi | 0.10% | 51.24 | 0.2% | $68.67m | |
| NVO | Novo Nordisk A/S | -0.02% | 61.30 | 0.1% | $64.41m | |
| RETA | Reata Pharmaceuticals, Inc. | -2.24% | 211.43 | 3.5% | $64.03m | |
| TPTX | Turning Point Therapeutics, Inc. | 2.72% | 59.95 | 0.0% | $40.48m |
Company Profile
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.